Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (375 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 19 May 2025 – 20 Aug 2026, limited by Bajaj Finserv Nifty 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Bajaj Finserv Nifty 50 Index Fund | Nifty 50 |
|---|---|---|
| 19 May 2025 | ₹100.00 | ₹100.00 |
| 26 Jun 2025 | ₹102.56 | ₹102.42 |
| 03 Aug 2025 | ₹98.93 | ₹98.48 |
| 11 Sep 2025 | ₹100.83 | ₹100.24 |
| 19 Oct 2025 | ₹103.69 | ₹103.06 |
| 26 Nov 2025 | ₹105.68 | ₹105.05 |
| 03 Jan 2026 | ₹105.75 | ₹105.54 |
| 10 Feb 2026 | ₹104.17 | ₹103.97 |
| 20 Mar 2026 | ₹92.81 | ₹92.66 |
| 28 Apr 2026 | ₹96.68 | ₹96.19 |
| 05 Jun 2026 | ₹94.30 | ₹93.67 |
| 13 Jul 2026 | ₹97.99 | ₹97.06 |
| 20 Aug 2026 | ₹98.26 | ₹97.14 |
| Metric | Bajaj Finserv · Direct NAV ₹9.90 Very High risk ★★☆☆☆ 1Y | Category median Index Funds · 375 funds |
|---|---|---|
| -2.72% | +5.66% | |
| — | +8.82% | |
| — | +9.15% | |
| — | +11.72% | |
| -1.39% | +7.67% | |
| -2.82% | — | |
| — | +12.67% | |
| — | +13.64% | |
| — | +12.84% | |
| Risk | ||
| 12.50% | 13.97% | |
| -0.74 | 0.24 | |
| -1.00 | 0.36 | |
| -14.92% | -16.12% | |
| Nifty 50 | — | |
| — | +0.84% | |
| — | 1.00 | |
| — | 102.2% | |
| — | 97.2% | |
| 0.31% | 0.36% | |
| ₹37.96Cr | ₹177.09Cr | |
| None | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| — | 35% | |
| Ilesh Savla | — | |
| 19 May 2025 | — | |
| 50 | — | |
| 53.4% | — | |
| 0.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.